Home » Stocks » LIXT

Lixte Biotechnology Holdings, Inc. (LIXT)

Stock Price: $3.33 USD 0.01 (0.30%)
Updated Jan 25, 2021 4:00 PM EST - Market closed
Market Cap 41.33M
Revenue (ttm) n/a
Net Income (ttm) -2.68M
Shares Out 11.17M
EPS (ttm) -0.24
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 25
Last Price $3.33
Previous Close $3.32
Change ($) 0.01
Change (%) 0.30%
Day's Open 3.44
Day's Range 3.22 - 3.41
Day's Volume 31,511
52-Week Range 3.09 - 4.35

News

GlobeNewsWire - 6 days ago

EAST SETAUKET, NY, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc . (NASDAQ: LIXT), a clinical-stage drug discovery company developing pharmacologically active drugs for u...

About LIXT

Lixte Biotechnology Holdings operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active d... [Read more...]

Industry
Biotechnology
Founded
2005
CEO
Dr. John S. Kovach
Employees
1
Stock Exchange
NASDAQ
Ticker Symbol
LIXT
Full Company Profile

Financial Performance

Financial Statements